Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

NCT06094478 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 900

Last updated 2026-05-20

No results posted yet for this study

Summary

Most stroke patients are initially evaluated at the closest hospital but some need to be transferred to a hospital that can provide more advanced care. The "Door-In-Door-Out" (DIDO) process at the first hospital can take time making transferred patients no longer able to get the advanced treatments. This study will help hospitals across the US "stand up" new ways to evaluate stroke patients, decide who needs to be transferred, and transfer them quickly for advanced treatment.

Conditions

  • Stroke, Acute
  • Ischemic Stroke, Acute
  • Hemorrhagic Stroke

Interventions

BEHAVIORAL

HI-SPEED Protocol

The HI-SPEED Protocol or Bundle consists of 7 components including 1) stroke screening scales, 2) imaging pathways, 3) telestroke operations, 4) a best practice alert, 5) stroke team communication tool, 6) door-to-needle (thrombolysis) treatment pathway, and 7) a standardized hand-off tool. This protocol will be implemented at each participating health system in clusters of 2 health systems.

Sponsors & Collaborators

  • University of Miami

    collaborator OTHER
  • Yale University

    collaborator OTHER
  • University of Cincinnati

    collaborator OTHER
  • Weill Medical College of Cornell University

    collaborator OTHER
  • University of Utah

    collaborator OTHER
  • Emory University

    collaborator OTHER
  • University of Michigan

    collaborator OTHER
  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH
  • University of Chicago

    lead OTHER

Principal Investigators

  • Shyam Prabhakaran, MD, MS · University of Chicago

  • Jane Holl, MD, MPH · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-17
Primary Completion
2028-01-31
Completion
2028-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06094478 on ClinicalTrials.gov